Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)
China
· Delayed Price · Currency is CNY 41.22
+2.07 (5.29%)
Apr 29, 2026, 3:04 PM CST
SHE:300255 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 37,884 | 57,074 | 18,372 | 11,957 | 5,036 | 7,472 | Upgrade
|
| Market Cap Growth | 106.10% | 210.66% | 53.65% | 137.41% | -32.59% | 31.26% | Upgrade
|
| Enterprise Value | 40,335 | 59,375 | 20,352 | 14,091 | 6,817 | 8,617 | Upgrade
|
| Last Close Price | 41.22 | 62.10 | 19.99 | 13.01 | 5.47 | 8.09 | Upgrade
|
| PE Ratio | - | - | - | - | 287.58 | 31.99 | Upgrade
|
| Forward PE | - | 12.44 | 12.44 | 12.44 | 12.44 | 12.44 | Upgrade
|
| PS Ratio | 43.42 | 65.22 | 17.82 | 8.48 | 2.16 | 2.52 | Upgrade
|
| PB Ratio | 32.34 | 48.86 | 11.96 | 6.64 | 1.65 | 2.43 | Upgrade
|
| P/TBV Ratio | 42.14 | 64.09 | 14.65 | 8.02 | 1.80 | 2.68 | Upgrade
|
| P/OCF Ratio | - | 1024.98 | 326.80 | 354.53 | 1611.41 | 2602.11 | Upgrade
|
| EV/Sales Ratio | 46.23 | 67.85 | 19.74 | 9.99 | 2.92 | 2.90 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | - | 41.33 | 22.68 | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | 63.13 | 26.59 | Upgrade
|
| Debt / Equity Ratio | 2.29 | 2.16 | 1.66 | 1.32 | 0.82 | 0.57 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | - | 15.10 | 4.58 | Upgrade
|
| Net Debt / Equity Ratio | 2.13 | 2.05 | 1.50 | 1.19 | 0.55 | 0.39 | Upgrade
|
| Net Debt / EBITDA Ratio | -152.52 | -95.80 | -21.58 | -1.99 | 10.26 | 3.15 | Upgrade
|
| Net Debt / FCF Ratio | -16.49 | -35.40 | -12.57 | -10.39 | -3.95 | -3.92 | Upgrade
|
| Asset Turnover | 0.19 | 0.20 | 0.23 | 0.27 | 0.42 | 0.61 | Upgrade
|
| Inventory Turnover | 0.60 | 0.57 | 0.62 | 0.85 | 0.56 | 0.60 | Upgrade
|
| Quick Ratio | 0.21 | 0.16 | 0.25 | 0.29 | 0.72 | 0.52 | Upgrade
|
| Current Ratio | 0.74 | 0.69 | 0.91 | 1.19 | 2.18 | 1.97 | Upgrade
|
| Return on Equity (ROE) | -26.97% | -27.18% | -15.83% | -51.43% | 0.33% | 7.81% | Upgrade
|
| Return on Assets (ROA) | -1.16% | -1.31% | -2.45% | -13.46% | 1.20% | 4.15% | Upgrade
|
| Return on Invested Capital (ROIC) | -2.30% | -2.51% | -4.60% | -26.38% | 1.34% | 7.22% | Upgrade
|
| Return on Capital Employed (ROCE) | -4.10% | -5.00% | -7.70% | -42.80% | 2.50% | 9.40% | Upgrade
|
| Earnings Yield | -0.94% | -0.63% | -1.36% | -10.37% | 0.35% | 3.13% | Upgrade
|
| FCF Yield | -0.40% | -0.12% | -1.00% | -1.72% | -8.50% | -4.08% | Upgrade
|
| Dividend Yield | - | - | - | - | 0.09% | 0.32% | Upgrade
|
| Payout Ratio | - | - | - | - | 708.02% | 26.50% | Upgrade
|
| Buyback Yield / Dilution | 0.92% | 0.68% | -0.58% | -4.91% | 6.27% | 0.23% | Upgrade
|
| Total Shareholder Return | 0.92% | 0.68% | -0.58% | -4.91% | 6.37% | 0.55% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.